A Randomized, Double-blind, Placebo Controlled, Crossover, Single Centre Phase I Study to Assess the Effect of Ticagrelor on Adenosine-induced Coronary Blood Flow Velocity in Healthy Male Subjects.

Trial Profile

A Randomized, Double-blind, Placebo Controlled, Crossover, Single Centre Phase I Study to Assess the Effect of Ticagrelor on Adenosine-induced Coronary Blood Flow Velocity in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2012

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Arterial thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Apr 2011 Actual end date (1 Mar 2011) added as reported by ClinicalTrials.gov.
    • 20 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top